Search

Your search keyword '"Angelopoulou, Maria K."' showing total 3 results
3 results on '"Angelopoulou, Maria K."'

1. Outcome and toxicity in relapsed hairy cell leukemia patients treated with rituximab.

Author

Angelopoulou, Maria K., Pangalis, Gerassimos A., Sachanas, Sotirios, Kokoris, Styliani I., Anargyrou, Konstantinos, Galani, Zaharoula, Kalpadakis, Christina, and Vassilakopoulos, Theodoros P.

Subjects
*LETTERS to the editor, *HAIRY cell leukemia, *PATIENTS
Abstract

A letter to the editor is presented in response to the article regarding the toxicity in patients with relapsed hairy cell leukemia who are treated with rituximab.

Published
2008
Full Text
View/download PDF

2. Retinoblastoma Gene Product and P21 (WAF1, CIP1) Protein Expression in Non Hodgkin's Lymphomas: A...

Author

Korkolopoulou[*], Penelope A., Angelopoulou, Maria K., Kontopidou, Flora N., Patsouris, Efstratios V., Christodoulou, Panayota N., Kittas, Christos N., Davaris, Panayotis, and Pangalis, Gerassimos A.

Subjects
*RETINOBLASTOMA, *HODGKIN'S disease, *LYMPHOMAS, *PATIENTS, *PROGNOSIS
Abstract

Evaluates the histochemical expression of retinoblastoma gene product (pRb) and WAF1/Cip1 in patients with non-Hodgkin's lymphomas (NHL). Patient characteristics; Detection of pRb in all cases of NHL; Percent of cases with p21 protein detection; Absence of significant prognostic value of pRb and p21 expression.

Published
2001

3. No evidence of splenic disease in patients with splenic marginal zone lymphoma undergoing splenectomy for autoimmune hemolytic anemia after monotherapy with rituximab.

Author

Kalpadakis, Christina, Pangalis, Gerassimos A., Sachanas, Sotirios, Rontogianni, Demetra, Korkolopoulou, Penelope, Milionis, Vassilis, Vassilakopoulos, Theodoros P., Papadaki, Helen A., and Angelopoulou, Maria K.

Subjects
*LYMPHOMAS, *SPLENECTOMY, *AUTOIMMUNE hemolytic anemia, *RITUXIMAB, *ABDOMINAL pain, *PATIENTS
Abstract

The article presents two case studies related to no evidence of splenic disease in patients with splenic marginal zone lymphoma (SMZL) undergoing splenectomy for autoimmune hemolytic anemia after monotherapy with rituximab. Topics include the first case was a 56 year-old male diagnosed with SMZL in September 2012, and the second case of a 60-year old woman first diagnosed with SMZL in May 2010 after she presented with abdominal pain and early satiety.

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results